-
{{ listItem.name }}快速筛选药品，用摩熵药筛
微信扫一扫-立即使用
-
产品立项评估及管线规划
-
数据定制服务
-
产业/行业调研
-
市场洞察咨询服务
-
报告大厅
已收录 68518 份 -
摩熵说直播
最新改良型新药及创新药立项开发
- GLP-1
【ChiCTR2100052752】The effectiveness of the Information-Motivation-Behavioural (IMB) based multimodal intervention (WALK-Beat-S) on anthropometric parameters, psychotic symptoms, physical activity levels and dietary behaviour of adults with schizophrenia: A pilot randomised controlled trial
ChiCTR2100052752
正在进行
/
/
/
2021-11-05
/
/
精神分裂症
The effectiveness of the Information-Motivation-Behavioural (IMB) based multimodal intervention (WALK-Beat-S) on anthropometric parameters, psychotic symptoms, physical activity levels and dietary behaviour of adults with schizophrenia: A pilot randomised controlled trial
The effectiveness of the Information-Motivation-Behavioural (IMB) based multimodal intervention (WALK-Beat-S) on anthropometric parameters, psychotic symptoms, physical activity levels and dietary behaviour of adults with schizophrenia: A pilot randomised controlled trial
852
To examine the acceptability and feasibility of the information-behavioural-motivation (IMB) based multimodal intervention (WALK-Beat-S program) and to evaluate its potential effects on body weight (BW) (primary outcome), other anthropometric parameters, including waist circumferences (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP), psychotic symptoms, physical activity levels and dietary behaviour, of adults with schizophrenia who are overweight or obese, compared with standard care at immediate post-intervention and one-month post-intervention.
随机平行对照
探索性研究/预试验
Participants will be randomly allocated into an intervention group (WALK-Beat-S program) or a control group (standard care) by using block randomisation on a 1:1 ratio, with a block size of six and eight. A clerical staff independent from the study will generate random codes by a random allocation software.
Assessor-blinded
N/A
/
38
/
2021-09-01
2022-09-30
/
1. Chinese adults and aged from 18 to 64 years; 2. BMI >= 23 kg/m2; 3. Have been diagnosed with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) or 5th edition (DSM-V), or the International Statistical Classification of Diseases and Related Health Problem, 10th Revision (ICD-10); 4. Able to read and write in Chinese, and able to understand Cantonese; 5. Mentally fit to provide consent as confirmed by attending psychiatrist; 6. Able to use apps installed on a smartphone (e.g., WeChat, Pedometer app).；
登录查看1. Currently receiving enrolled in diet control and/or regular physical activity program; 2. Any physical impairment that barrier to participating in an exercise program; 3. Prior bariatric surgery; 4. Currently receiving cancer treatment; 5. Having the problem of harmful or dependent use of the substance; 6. Diagnosis of an eating disorder, including anorexia nervosa, bulimia nervosa, mental retardation or organic brain disorders; 7. Breastfeeding or being pregnant at recruitment.；
登录查看N/A
852
N/A的其他临床试验
- Pilot study on the effect of mindfulness on the changes in loneliness and psychological outcomes and their association with changes in microbiota and inflammatory markers
- 请与我们联系完善研究实施负责单位、试验主办单位信息。 Emotion GPS: The Effectiveness of the Stepped-care model in a Mental Health Community Setting in Hong Kong
- Dietary interventions on constipation and gut outcomes for people with Parkinson’s disease
- A randomised controlled trial on effects of a home-based exercise programme incorporating mindfulness and yoga practice on motor symptoms for people with Parkinson’s Disease
- The effectiveness of the Information-Motivation-Behavioural (IMB) based multimodal intervention (WALK-Beat-S) on anthropometric parameters, psychotic symptoms, physical activity levels and dietary behaviour of adults with schizophrenia: A pilot randomised controlled trial
- Lay health worker as an example of medical task-shifting: Design of a pragmatic randomized controlled trial for diabetes prevention in people living in inadequate housing
- 鼻喷流感病毒载体新冠肺炎疫苗（DelNS1-2019-nCoV-RBD-OPT1）III期临床试验
- Chau Pak Chun Janita：请与我们联系上传伦理审查文件 Effects of a social participation-focused virtual reality intervention on the physical, psychological and social outcomes of community-dwelli
- Repetitive Negative Thinking of Patients with Common Mental Disorders
- The effectiveness of MICM to improve medication adherence for dual-diagnosed patients
- Multi-center population pharmacokinetic study of intravenous vancomycin in adults in Hong Kong and development of web-based individual dose optimization interface
- A randomized trial on the comparative effects of 'mindfulness in stillness' versus 'mindfulness in motion' on physio-psycho-spiritual wellbeing in people with Parkinson's disease
- Mindfulness-based Therapeutic Parenting Group (MTPG) for Parents with Adverse Childhood Experiences (ACEs): A Randomized Controlled Trial
- Diabetes educator assisted management study of diabetes
- Decline in Radioiodine use but not total thyroidectomy in thyroid cancer patients treated in United Arab Emirates- A Retrospective Study
- Please upload approved file of ethical committee. Dual Spectroscopic Assessment (DSA) on tumor margin of breast cancer during breast conserving surgery with Near infrared (NIR) and Raman spectroscopy: a novel intraoperative ma
- Dual Spectroscopic Assessment (DSA) on tumor margin of breast cancer during breast conserving surgery with near infrared and raman spectroscopy: A novel intraoperative margin assessment device
- Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic
- Effects of Qigong training on physical and psychological health in breast cancer survivors: A randomized controlled trial
- Genetics and genome sequencing study of pelvic organ prolapse patients
最新临床资讯
-
重磅！2025年度JCR期刊分区发布
-
体重平均下降 15.4%！先为达全球首创偏向性 GLP-1 肥胖 III 期数据首次公布
-
TGF-β 胰腺导管腺癌
中国医药生物技术协会2025-06-18
-
肿瘤治疗性疫苗
医麦创新药2025-06-18
-
β-地中海贫血 β-地
医麦创新药2025-06-18
-
D&D Pharmatech Inc. GC GLP-1/GCG
药时空2025-06-18
-
MTAP PRMT5 AI
晶泰科技2025-06-18
-
肥胖 箕星 超重
箕星药业科技2025-06-18
-
β-地中海贫
邦耀实验室2025-06-18
-
抽动症 神经发育障碍 BD项目002
美柏资本2025-06-18
18983288589（微信同号）
18983288589（微信同号）
18908392210（微信同号）
18980413049
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: tyc7111cc太阳成集团 tyc7111cc太阳成集团企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网